产品介绍：
产品说明
一般描述
It is an encapsulated catalyst (EnCat®), wherein palladium acetate is microencapsulated within a polyurea matrix, which prevents palladium leaching.
应用
Reaxa Technology
可回收利用的负载化催化剂体系，在 C-C 键的形成和还原过程中可简化钯的除去。
虽然 Pd EnCat 40 在许多转化中都表现出优异的性能，但是具有较低基质含量的 Pd EnCat 30 也表现出相似的性能，在类似的条件下，在保持 Pd EnCat 40 机械稳定性的同时还具有改善的动力学特性。
包装
1, 10, 100 g in glass bottle
特点和优势
The advantages of using Pd EnCat® catalysts are:
- low residual metal levels in crude product
- easy recovery of catalyst
- compatibility of immobilized metal with various ligands to effect C-C bond forming reactions
- safer and easier to handle than Pd/C for hydrogenation
- efficiency and economy gains through recovery and recycling
其他说明
基质含量 30%
法律信息
Pd Encat 技术已申请国际专利，包括 PCT/GB 02/03135。
EnCat is a registered trademark of Reaxa Ltd.
基本信息
| MDL编号 | MFCD06798790 |
| NACRES | NA.22 |
产品性质
| 质量水平 | 200 |
| 包含 | 0.37-0.44 mmol/g palladium |
| reaction suitability | core: palladium reaction type: Buchwald-Hartwig Cross Coupling Reaction reaction type: Heck Reaction reaction type: Hiyama Coupling reaction type: Negishi Coupling reaction type: Sonogashira Coupling reaction type: Stille Coupling reaction type: Suzuki-Miyaura Coupling reagent type: catalyst |
| 标记范围 | 0.4 mmol/g Pd loading |
安全信息
| 象形图 |    |
| 警示用语： | Danger |
| 危险声明 | H228 - H315 - H319 - H360Df - H373 - H412 |
| 预防措施声明 | P202 - P210 - P273 - P302 + P352 - P305 + P351 + P338 - P308 + P313 |
| 危险分类 | Aquatic Chronic 3 - Eye Irrit. 2 - Flam. Sol. 2 - Repr. 1B - Skin Irrit. 2 - STOT RE 2 Inhalation |
| 靶器官 | Nervous system |
| 储存分类代码 | 4.1B - Flammable solid hazardous materials |
| WGK | WGK 3 |
| 闪点(F) | -9.4 - -7.6 °F |
| 闪点(C) | -23 - -22 ℃ |
| 个人防护装备 | Eyeshields, Faceshields, Gloves, type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges |
